Zdrowie i gospodarka · 06/03/2017

FDA to Host Public Meeting on Patient-Focused Drug Development for Autism, Seeks Public Comments

The US Food and Drug Administration is hosting a public meeting to gather patient perspectives on autism treatment approaches and daily life, as part of its performance commitments under the Prescription Drug User Fee Act (PDUFA V)